Diabetic Retinopathy

A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report. Read More

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults. Read More

The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States. Read More

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries. Read More

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read More

Research to Prevent Blindness has awarded a grant of $100,000 to Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases. Read More